Literature DB >> 31257986

Deregulated MTOR (mechanistic target of rapamycin kinase) is responsible for autophagy defects exacerbating kidney stone development.

Rei Unno1, Tsuyoshi Kawabata2, Kazumi Taguchi1, Teruaki Sugino1, Shuzo Hamamoto1, Ryosuke Ando1, Atsushi Okada1, Kenjiro Kohri1, Tamotsu Yoshimori3, Takahiro Yasui1.   

Abstract

Kidney stone disease is a lifestyle-related disease prevalent in developed countries; however, effective medical treatment for the disease is not yet well established. As cellular damage in renal tubular cells (RTCs) is responsible for the disease, here, we focused on the role of macroautophagy/autophagy in RTCs. We found that autophagic activity was significantly decreased in mouse RTCs exposed to calcium oxalate (CaOx) monohydrate crystals and in the kidneys of GFP-conjugated MAP1LC3B (microtubule- associated protein 1 light chain 3 beta) transgenic mice with CaOx nephrocalcinosis induced by glyoxylate. This caused accumulation of damaged intracellular organelles, such as mitochondria and lysosomes, the normal functioning of which is mediated by functional autophagy. An impairment of autophagy was also observed in the mucosa with plaques of CaOx kidney stone formers. We determined that the decrease in autophagy was caused by an upregulation of MTOR (mechanistic target of rapamycin kinase), which consequently resulted in the suppression of the upstream autophagy regulator TFEB (transcription factor EB). Furthermore, we showed that an MTOR inhibitor could recover a decrease in autophagy and alleviate crystal-cell interactions and the formation of crystals associated with increased inflammatory responses. Taken together, we conclude that autophagy compromised by MTOR deregulation is a fundamental feature in the pathology of kidney stone formation, and propose that chemical inhibition of MTOR could be a prospective strategy for disease suppression.Abbreviations: ACTB: actin, beta; CaOx: calcium oxalate; CKD: chronic kidney disease; COM: calcium oxalate monohydrate; LGALS3/galectin-3: lectin, galactose binding, soluble 3; GFP: green fluorescent protein; GOX: glyoxylate; HE: hematoxylin and eosin; MAPLC3B: microtubule- associated protein 1 light chain 3 beta; MTOR: mechanistic target of rapamycin kinase; NAC: N-acetyl-L-cysteine; ROS: reactive oxygen species; RTC: renal tubular cell; SQSTM1/p62: sequestosome 1; TFEB: transcription factor EB; TEM: transmission electron microscopy; tfLC3: tandem fluorescent-tagged LC3; 3-MA: 3-methyladenine.

Entities:  

Keywords:  Autophagy; calcium oxalate; kidney stone; mechanistic target of rapamycin kinase; transcription factor EB

Year:  2019        PMID: 31257986      PMCID: PMC7138204          DOI: 10.1080/15548627.2019.1635382

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  52 in total

Review 1.  mTOR signaling in growth control and disease.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  Cell       Date:  2012-04-13       Impact factor: 41.582

Review 2.  Stones in 2012: epidemiology, prevention and redefining therapeutic standards.

Authors:  Andreas Neisius; Glenn M Preminger
Journal:  Nat Rev Urol       Date:  2013-01-08       Impact factor: 14.432

3.  Role of mTOR in podocyte function and diabetic nephropathy in humans and mice.

Authors:  Markus Gödel; Björn Hartleben; Nadja Herbach; Shuya Liu; Stefan Zschiedrich; Shun Lu; Andrea Debreczeni-Mór; Maja T Lindenmeyer; Maria-Pia Rastaldi; Götz Hartleben; Thorsten Wiech; Alessia Fornoni; Robert G Nelson; Matthias Kretzler; Rüdiger Wanke; Hermann Pavenstädt; Dontscho Kerjaschki; Clemens D Cohen; Michael N Hall; Markus A Rüegg; Ken Inoki; Gerd Walz; Tobias B Huber
Journal:  J Clin Invest       Date:  2011-05-23       Impact factor: 14.808

4.  Mechanism of apoptosis induced by a lysosomotropic agent, L-Leucyl-L-Leucine methyl ester.

Authors:  T Uchimoto; H Nohara; R Kamehara; M Iwamura; N Watanabe; Y Kobayashi
Journal:  Apoptosis       Date:  1999-10       Impact factor: 4.677

5.  Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury.

Authors:  Ikuko Maejima; Atsushi Takahashi; Hiroko Omori; Tomonori Kimura; Yoshitsugu Takabatake; Tatsuya Saitoh; Akitsugu Yamamoto; Maho Hamasaki; Takeshi Noda; Yoshitaka Isaka; Tamotsu Yoshimori
Journal:  EMBO J       Date:  2013-08-06       Impact factor: 11.598

6.  Autophagic clearance of mitochondria in the kidney copes with metabolic acidosis.

Authors:  Tomoko Namba; Yoshitsugu Takabatake; Tomonori Kimura; Atsushi Takahashi; Takeshi Yamamoto; Jun Matsuda; Harumi Kitamura; Fumio Niimura; Taiji Matsusaka; Hirotsugu Iwatani; Isao Matsui; Junya Kaimori; Hidetaka Kioka; Yoshitaka Isaka; Hiromi Rakugi
Journal:  J Am Soc Nephrol       Date:  2014-04-03       Impact factor: 10.121

7.  Novel effect of the inhibitor of mitochondrial cyclophilin D activation, N-methyl-4-isoleucine cyclosporin, on renal calcium crystallization.

Authors:  Kazuhiro Niimi; Takahiro Yasui; Atsushi Okada; Yasuhiko Hirose; Yasue Kubota; Yukihiro Umemoto; Noriyasu Kawai; Keiichi Tozawa; Kenjiro Kohri
Journal:  Int J Urol       Date:  2014-03-24       Impact factor: 3.369

Review 8.  Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress.

Authors:  Shomit Sengupta; Timothy R Peterson; David M Sabatini
Journal:  Mol Cell       Date:  2010-10-22       Impact factor: 17.970

9.  TFEB links autophagy to lysosomal biogenesis.

Authors:  Carmine Settembre; Chiara Di Malta; Vinicia Assunta Polito; Moises Garcia Arencibia; Francesco Vetrini; Serkan Erdin; Serpil Uckac Erdin; Tuong Huynh; Diego Medina; Pasqualina Colella; Marco Sardiello; David C Rubinsztein; Andrea Ballabio
Journal:  Science       Date:  2011-05-26       Impact factor: 47.728

Review 10.  Autophagy in the pathogenesis of disease.

Authors:  Beth Levine; Guido Kroemer
Journal:  Cell       Date:  2008-01-11       Impact factor: 41.582

View more
  7 in total

Review 1.  Lysosome Depletion-Triggered Autophagy Impairment in Progressive Kidney Injury.

Authors:  Xiao-Cui Chen; Zhi-Hang Li; Chen Yang; Ji-Xin Tang; Hui-Yao Lan; Hua-Feng Liu
Journal:  Kidney Dis (Basel)       Date:  2021-05-25

2.  Macrophage Function in Calcium Oxalate Kidney Stone Formation: A Systematic Review of Literature.

Authors:  Kazumi Taguchi; Atsushi Okada; Rei Unno; Shuzo Hamamoto; Takahiro Yasui
Journal:  Front Immunol       Date:  2021-05-24       Impact factor: 7.561

3.  Inhibition of the Wnt/β-catenin signaling pathway reduces autophagy levels in complement treated podocytes.

Authors:  Zhaocheng Dong; Haoran Dai; Yu Gao; Zhendong Feng; Wenbin Liu; Fei Liu; Zihan Zhang; Fang Ma; Xinran Xie; Zebing Zhu; Weijing Liu; Baoli Liu
Journal:  Exp Ther Med       Date:  2021-05-09       Impact factor: 2.447

4.  Resveratrol Attenuates Oxalate-Induced Renal Oxidative Injury and Calcium Oxalate Crystal Deposition by Regulating TFEB-Induced Autophagy Pathway.

Authors:  Yue Wu; Yang Xun; Jiaqiao Zhang; Henglong Hu; Baolong Qin; Tao Wang; Shaogang Wang; Cong Li; Yuchao Lu
Journal:  Front Cell Dev Biol       Date:  2021-02-25

Review 5.  Intracellular galectins sense cytosolically exposed glycans as danger and mediate cellular responses.

Authors:  Ming-Hsiang Hong; I-Chun Weng; Fang-Yen Li; Wei-Han Lin; Fu-Tong Liu
Journal:  J Biomed Sci       Date:  2021-03-04       Impact factor: 8.410

6.  Regulation of Laminaria Polysaccharides with Different Degrees of Sulfation during the Growth of Calcium Oxalate Crystals and their Protective Effects on Renal Epithelial Cells.

Authors:  Wei-Bo Huang; Guo-Jun Zou; Gu-Hua Tang; Xin-Yuan Sun; Jian-Ming Ouyang
Journal:  Oxid Med Cell Longev       Date:  2021-08-26       Impact factor: 6.543

7.  The role of autophagy in calcium oxalate kidney stone: A systematic review of the literature.

Authors:  Hao Li; Yingjian Zhou; Wenchao Xu; Jihong Liu; Shaogang Wang; Hongyang Jiang
Journal:  Front Physiol       Date:  2022-09-21       Impact factor: 4.755

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.